MedTrace Logo

Effects of Dexmedetomidine on the Intraoperative Electroencephalogram During Endarterectomy Surgery

NCT00710437 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2017-05-30

No results posted yet for this study

Summary

During elective carotid endarterectomy surgery, dexmedetomidine, an FDA approved medication, is now given as part of our standard anesthetic regimen based upon its reported ability to decrease anesthetic requirements and improve the peri-operative hemodynamic profile without compromising the EEG monitoring that is used during these procedures. Although this is consistent with our clinical impression, the effects of dexmedetomidine on the perioperative course and EEG monitoring have not been objectively evaluated at our institution.

Conditions

  • Endarterectomy, Carotid

Interventions

DRUG

Dexmedetomidine

Steady state infusion 0.007 mcg/kg/min

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Neal W Fleming, M.D., Ph.D. · Director, Cardiovascular and Thoracic Anesthesiology, UC Davis, Department of Anesthesiology and Pain Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2009-05-31
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00710437 on ClinicalTrials.gov